Hemodynamic effects of ephedra-free weight-loss supplements in humans

American Journal of Medicine

Volumn 118, Issue 9, 2005, Pages 998-1003

  Haller, Christine A ^a,b   Benowitz, Neal L ^a   Jacob III, Peyton ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Citrus aurantium; Dietary supplement; Pharmacology

Indexed keywords

ADVANTRA Z; OCTOPAMINE; OXEDRINE; PLACEBO; XENADRINE EFX;

ADULT; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR EFFECT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; EPHEDRA; FEMALE; HEART HEMODYNAMICS; HEART RATE; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUR ORANGE; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; CITRUS; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; MALE; PLANT EXTRACTS; REFERENCE VALUES;

EID: 24744437314     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.02.034     Document Type: Article

References (20)

1. US Food and Drug Administration. Questions and answers about FDA's actions on dietary supplements containing ephedrine alkaloids 2004 Available at: http://www.fda.gov/oc/initiatives/ephedra/february2004/qa_020604.html. Accessed May 28
2. P.G. Shekelle, M.L. Hardy, S.C. Morton Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance JAMA 289 2003 1537 1545
3. D. Samenuk, M.S. Link, M.K. Homoud Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine Mayo Clin Proc 77 2002 12 16
4. C.A. Haller, N.L. Benowitz Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids N Engl J Med 343 2000 1833 1838
5. A. Fugh-Berman, A. Myers Citrus aurantium, an ingredient of dietary supplements marketed for weight loss current status of clinical and basic research Exp Biol Med 229 2004 698 704
6. G. D'Andrea, S. Terrazzino, D. Fortin, P. Cocco, T. Balbi, A. Leon Elusive amines and primary headaches historical background and prospectives Neurol Sci 24 suppl 2 2003 S65 S67
7. C.M. Brown, J.C. McGrath, J.M. Midgley Activities of octopamine and synephrine stereoisomers on α-adrenoceptors Br J Pharmacol 93 1988 417 429
8. N.L. Benowitz Clinical pharamcology of caffeine Ann Rev Med 41 1990 277 288
9. N.J. Brown, D. Ryder, R.A. Branch A pharmacodynamic interaction between caffeine and phenylpropanolamine Clin Pharmacol Ther 50 1991 363 371
10. C.A. Haller, P. Jacob, N.L. Benowitz Enhanced stimulant and metabolic effects of ephedrine and caffeine Clin Pharmacol Ther 75 2004 259 273
11. N.C. Bouchard, H.A. Greller, R.S. Hoffman, L.S. Nelson Ischemic stroke from "ephedra-free" dietary supplement containing synephrine (abstract) J Toxicol Clin Toxicol 42 2004 137
12. J.M. Nasir, S.J. Durning, M. Ferguson, H.S. Barold, M.C. Haigney Exercise-induced syncope associated with QT prolongation and ephedra-free Xenadrine Mayo Clinic Proc 79 2004 1059 1062
13. D.L. Nykamp, M.N. Fackih, A.L. Compton Possible association of acute lateral-wall myocardial infarction and bitter orange supplement Ann Pharmacother 38 2004 812 816
14. Adverse Event Reporting for Dietary Supplements An Inadequate Safety Valve 2001 Office of the Inspector General, HHS Washington, DC OEI-01-00-00180
15. C.M. Colker, D.S. Kalman, G.C. Torina, T. Perlis, C. Street Effects of Citrus aurantium extract, caffeine, and St. John's wort on body fat loss, lipid levels, and mood states in overweight healthy adults Curr Ther Res 60 1999 145 153
16. S.R. Penzak, M.W. Jann, J.A. Cold, Y.Y. Hon, H.D. Desai, B.J. Gurley Seville (sour) orange juice synephrine content and cardiovascular effects in normotensive adults J Clin Pharmacol 41 2001 1059 1063
17. G. Calapai, F. Firenzuoli, A. Saitta, F. Squadrito Antiobesity and cardiovascular toxic effects of Citrus aurantium extracts in the rat a preliminary report Fitoterapia 70 1999 586 592
18. http://www.randomization.com. Accessed June 2, 2004.
19. P. Jacob, C.A. Haller, M. Duan, L. Yu, M. Peng, N.L. Benowitz Determination of ephedra alkaloids and caffeine levels in dietary supplements and biological fluids J Anal Toxicol 28 2004 152 159
20. J.H. Hengstmann, H. Aulepp Pharmacokinetics and metabolism of 3H-synephrine Arzneimittelforschung 28 12 1978 2326 2331